All lobbying filings

Chiesi USA, Inc.

Chiesi USA, Inc. filed a Q3 report for Chiesi USA, Inc. on October 20, 2026.

Lobbying for Chiesi USA, Inc.

As filed: CHIESI USA, INC. for CHIESI USA, INC.

All filings by Chiesi USA, Inc. · Everything Chiesi USA, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$280,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

North Carolina

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to Therapies for Rare Diseases - no specific legislation. General healthcare access and innovation matters, and regulatory pathway topics - no specific legislation. Implementation of the Joe Fiandra Access to Home Infusion Act of 2025 (Public Law 119-21), including CMS rulemaking and home infusion therapy reimbursement issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.